- 4 hours ago
Category
📺
TVTranscript
00:00The leukemia is a disease.
00:02On the one hand, he is a disease.
00:04He is a disease.
00:05He is a disease if he was a disease.
00:07If he was a son or a son, he could get to go to the patient.
00:10There is a disease that is a disease that is usually in the patient.
00:14The leukemia itself is not a disease.
00:17It is a disease that is a disease that is going to happen.
00:20Many of the people who have access to the patient,
00:23are only in the care of the patient without a reason.
00:28There is a disease that is not a disease.
00:30We have to look at this disease.
00:33This disease is one of the reasons.
00:44Welcome to the video of the video.
00:47This video is about Novartis.
00:49It is a very important topic.
00:51It is a subject of the disease or leukemia.
00:54To focus on this topic,
00:56I will see you in the next video.
00:58I hope you will be able to see your results.
00:59We will be able to see you today.
01:00We are very good in the video.
01:02I am with Dr. Eynas Nijar and Dr. Mحمd Abu-Hriqa.
01:05From the center of Abu-Hriqa,
01:06from the center of Abu-Hriqa.
01:07Welcome to our video.
01:09Thank you for today.
01:11We are very grateful for you.
01:14I would like to start with the first question.
01:16We are talking about the diseases of leukemia.
01:19I will speak about leukemia.
01:22On a video,
01:23but not upon the mind,
01:24I do not know what the trauma is
01:25from therate.
01:26Can you tell me more about the supply?
01:28leukemia is a uh,Не
01:29um banks that will define more
01:32I also have to ask the question about the
01:32Nukha which is available in the Nukha.
01:38The Nukha is actually
01:39from a German language.
01:43It has meaning that
01:45the Nukha is also
01:48in the blood.
01:49This is going to be
01:51to increase the Nukha
01:52in the Nukha
01:55more than the natural way.
01:56In a non-stayst way
01:58and also increase the pressure in the blood.
02:02There are many different types of blood, leukemia,
02:07and leukemia.
02:13The leukemia is the most important thing,
02:19but the number we want to talk about is the C.M.
02:22What do you think about leukemia?
02:29Yes.
02:31As you said, there are types of leukemia,
02:37and leukemia, and leukemia,
02:44and leukemia, and leukemia,
02:50and leukemia,
02:54the leukemia,
02:55the C.M.
02:56the E.M.
02:57.
03:01leukemia
03:02leukemia
03:03the C.L.
03:07and leukemia
03:08the C.M.
03:15or the CNIL in the Linkedin Leukemia NK-EL F-C.
03:25It is a smooth transition to the CNIL in the NK-EL F-C.
03:33بشكل مفرط بسبب طفرة وراثية مكتسبة تحصل في هذه الخلايا
03:41وتأدي إلى تكاثرها بشكل عالي
03:43فارتفاع فكريات الدم البيضاء ولها أعراض طبعا مختلفة
03:49دكتور ذكرت كلمة طفرة وراثية
03:52على طول واحد من يسمع كلمة وراثية
03:55يفبال هل هو هل مرض وراثي
03:57إذا كان في الأب أو الأم ممكن ينتقل للأطفال
04:00Is the doctor not aware of this information?
04:03No, this is not true.
04:07The leukemia is not used to be used.
04:13If the patient has leukemia, it will be used to the children.
04:19This is not true.
04:21When we explain that diseしい leukemia is not a very actual person,
04:28but even encontrar vimos in which there are no diseases that are illnesses.
04:41The leukemia here is a own disease which is new genderless father.
04:48This insulin cannot be unaware of.
04:50to the children.
04:54Do we remember that they don't come from the children,
05:00but do we have a different way to the children of their age,
05:06or to the children of their age,
05:08or to the children of their age,
05:08or to the children of their age?
05:09Well, the leukemia is more likely than the children of their age.
05:22Every age of age, the leukemia may be more likely than the leukemia.
05:30Especially the leukemia is more likely than the children of their age.
05:33Do you think this is a different cause?
05:37We talked about that it's not a different cause,
05:39but are there other causes?
05:40I don't know why there's a leukemia in a different person,
05:45but there are some things that can increase the importance of leukemia.
05:50For example, such as the leukemia,
05:54such as the leukemia,
05:56such as the leukemia,
05:56such as the years,
05:57such as the leukemia,
06:01such as the leukemia,
06:02such as the leukemia,
06:06such as the leukemia,
06:07such as the leukemia,
06:08such as the leukemia.
06:08Okay.
06:09Thank you, Dr.
06:10Dr.
06:10I'm sorry,
06:11there are a lot of information for me.
06:15I want to know a lot more about the leukemia.
06:19Dr. Dr.
06:20Muhammad,
06:20if I can,
06:22I can,
06:23I can,
06:23I can,
06:24I can,
06:24I can,
06:24I can,
06:26I can,
06:26I can't,
06:27but what is the,
06:29I have to tell,
06:32unless it's the case,
06:34you can,
06:34I can,
06:34I can I can tell you.
06:36That's the case.
06:38Yes.
06:39Is it,
06:41the leukemia,
06:42the leukemia,
06:42the ETA,
06:45First, I would like everyone to conduct the study of the clinical trial or the year-old by every 6
06:56or so, depending on what he can do.
07:00This is one of the things you can find in the research method.
07:04This is the beginning of the disease.
07:06There are many diseases that don't exist in leukemia.
07:11There are many diseases that have come to us today.
07:16There are only diseases that have come to us without any reason.
07:22We have to look at this disease.
07:27But the disease that we can say that
07:31we have to think about that.
07:37Like why the disease that the disease might be missed.
07:38To heal up there without any reason.
07:40Without any reason,
07:41the disease might fall unless.
07:45The disease might need to be achieved.
07:51Like the disease might fall because of the disease.
07:53The disease might fall in some ways whether or not.
07:57Of course, this is the most important thing that we have to make the person or the person who is
08:03concerned about this person
08:04to go to see a different person, so that they can do the same thing as we call it, or
08:11the CVC
08:12which is the reason why the person needs to be used to be used to the doctor.
08:18So this is the effect that we have to do more.
08:20Because of what we have said, the leukemia is to cut the blood pressure without a doubt in the heart
08:26of the blood.
08:27So it's the plant that is making all the blood cells that are present in the blood.
08:33So the plant is to cut the blood pressure and the blood pressure and the blood pressure.
08:39It helps the body to get rid of the blood pressure.
08:44So when you get the correct ones in the same way, you will take the correct ones who need to
08:52be able to get oxygen.
08:53So the person, as he said, Dr. Muhammad, feels like it's a pain, so it's a pain in the right
08:58hand.
08:58So he feels like it's not a pain in the right hand.
09:02So the correct ones that are not the oxygen that go to the body as he says.
09:08and also the symptoms, as we said,
09:11so that the physical body will be high in the blood,
09:15so it will be easy to find the symptoms
09:18if the patient is not possible for the symptoms.
09:23This is because the symptoms of the stomach
09:26can't be able to get the symptoms like the body is supposed to be.
09:30You remember something very important, the symptoms of the stomach
09:36It's important to think about the symptoms and the symptoms, but they don't agree with them.
09:40But the way I agree with them is how the symptoms get back to the symptoms.
09:47I see these symptoms very important.
09:50It's nice that the person knows it in a way.
09:53Of course.
09:53Even if the symptoms of the symptoms of the symptoms of the symptoms, the symptoms of the symptoms of the
09:59symptoms of the symptoms.
09:59My apologies.
10:01That was it.
10:06We've discussed with upcoming schedules Student International for others.
10:17What Typical medicine will be.
10:19He has an emotional nightmare.
10:22What are the symptoms of L shovels?
10:24Dr. Mحمad, if you can, we can add them on.
10:27Of course, the CML, most of the times when they are in the beginning, they are usually in the
10:35early phase, or chronic phase.
10:39To be sure that the CML or leukemia is the early phase, they must do
10:46They will perform a research study and then they will see the disease in a long period of time.
10:57When they see the disease in a long period of time, the disease is usually used by the Tarrosine Kinase
11:08Inhibitor
11:08or one of the tools that we call the infectious disease
11:11which is to treat the disease, the birth of this disease
11:20which is the same
11:21and this disease has been offered for about 25 years now
11:28and it is about healing
11:32and the external disease is really good and good
11:37and the response is very good to the extent that the disease can live in a natural life like them
11:44or other.
11:46In the past, if the disease was in the extended phase,
11:52we call it accelerated phase or blast phase,
11:55and in the past, they used chemotherapy, and they used to need to cure the disease.
12:00But this is now very low, because of this disease.
12:05Yes, it is.
12:07The new medicine that has been found was, as I said,
12:12about the treatment of the disease and the treatment of the disease,
12:15but it is very low.
12:18It is very low if they didn't have the treatment of the disease,
12:21which is the tyrosine kinase inhibitors.
12:24As I said, Dr. Mohamad, it is a treatment that is very important,
12:28but it is important to the treatment of the disease,
12:32the leukemia, the CML cells,
12:35which is located in the cell,
12:37which is located only against these cells,
12:39and it does not affect the other cells.
12:41So that's why we say that it is a treatment of the disease,
12:44only against the CML cells,
12:46which is located only against the CML cells.
12:54So the TMRC cells,
12:56that the CML cells,
12:57which is like a model for the Island types of cells,
13:03and that's not only for the gene of the CML cells,
13:08so that the placebo cells itself has changed.
13:11there is a serum from the tyrosine kinase enzyme
13:15that is involved with these skulls.
13:17The cause for the treatment
13:19will make the tyrosine kinase enzyme
13:22to make the teeth so that the cellulose
13:28will break the follicle.
13:29Therefore, it can work.
13:30It's so important.
13:32That call her ?
13:32Do you call it as a serum ?
13:34The serum the serum also is so much
13:37because this tyrosine kinase enzyme
13:39It's like the switch on, which allows the cells to get better or to stop.
13:48In the leukemia, the tyrosine kinase enzyme allows the cells to get better.
13:55In the procedure, it allows the enzyme to start to get better, and it allows the cells to get better.
14:02And it allows them to get better.
14:05Do you remember that?
14:09But it's a very good idea.
14:12We're talking about chemotherapy, chemotherapy, chemotherapy, and chemo therapy.
14:17And it's always an example that can be really good.
14:22But you remember that I love it.
14:25Do you like it?
14:28Do you like it?
14:29It's a good idea.
14:30Yes, that's a good idea.
14:33It's a good idea.
14:35It's a good idea.
14:37It can be a bad idea.
14:41So, when the patient takes care of the TKI inhibitors and comes back to the patient, it becomes like a
14:53sick disease where he can live with the patient and it doesn't affect the whole life of his life.
15:01He doesn't have CML.
15:03Yes, that's a very good idea.
15:08One of the things that we're talking about is that the patient is very strong.
15:14I don't want to say it in this way, but it's a very good idea.
15:18I don't want to say it in my life.
15:21The thing that you say is something that we feel like the patient is in this situation.
15:29It's very good.
15:30Or that's the dream.
15:32This is the start of the treatment of the patient, the treatment that is only due to the cancer or
15:40the patient who has been exposed.
15:42I'm sorry.
15:43The concern is that the topic is somewhat unique, but I feel the power and I would feel positive.
15:54I want to discuss something that's important in the video, which is the most important part of the video, which
16:01is the most important part of the video.
16:03Are these are the problems that you can see in the video?
16:07We are in the internet, the information is available to everyone and in every place.
16:14But unfortunately, all the information is correct or wrong.
16:19There are many people who are interested in reading Google.
16:26Dr. Google told me.
16:29Dr. Chabotty.
16:30Dr. Chabotty.
16:32Dr. Chabotty.
16:33Dr. Chabotty.
16:47Dr. Chabotty.
16:49Dr. Chabotty.
16:49Dr. Chabotty.
16:50Dr. Chabotty.
16:51Dr. Chabotty.
16:51Dr. Chabotty.
16:53Dr. Chabotty.
16:54Dr. Chabotty.
16:55Dr. Chabotty.
16:58Dr. Chabotty.
17:00Dr. Chabotty.
17:01Dr. Chabotty.
17:01Dr. Chabotty.
17:03Dr. Chabotty.
17:04Dr. Chabotty.
17:05Dr. Chabotty.
17:06Dr. Chabotty.
17:07Dr. Chabotty.
17:11Dr. Chabotty.
17:11Dr. Chabotty.
17:12Dr. Chabotty.
17:13Dr. Chabotty.
17:13Dr. Chabotty.
17:14The person who read on the CML is a symptom, and it's a symptom, and it's a symptom.
17:22Is this information correct or wrong?
17:27I'd rather say that we have 25 years from the history of the Tyrosin Kainers Inhibitors
17:38There were many studies in the world around the world.
17:42They saw that if people were able to respond to the treatment in a certain way,
17:48in the early stages,
17:50and they were able to follow their treatment in a certain way,
17:55they could be in the middle of the human life in the entire society.
18:03So this is something that they live in.
18:06It's something that they can live with, like a patient disease.
18:13It's not like someone who can imagine like a patient disease,
18:19or a patient disease,
18:20but there are things we can do to improve the treatment.
18:27Thank you, Dr.
18:29I have another information.
18:33I would like to know if it's a patient disease,
18:35or if it's a patient disease,
18:36or if it's a patient disease,
18:40or if it's a patient disease.
18:50And for some reason,
18:52I would like to say,
18:55that I've lost the information about this treatment,
18:57because it's a treatment,
18:58but we know that it's been 25 years.
19:00There are different kinds of different types,
19:03but it's different.
19:05It's different.
19:08It's different than the patients with.
19:17However,
19:22it's very different.
19:23It's different.
19:24It's different from people.
19:35Yeah, I think you are going to get into a problem with this issue.
19:38Because it also affects a lot of things.
19:42On the patient's mental illness and the health care.
19:44And the idea that the CML is a disease that is a disease that is not a disease that is
19:50a disease that is also a disease that is a disease or a disease that is a disease that is
19:51very difficult.
19:54I think that when someone gets infected with the virus, they can be sick with the disease.
20:04We don't have to go back to the surgery.
20:07We have to wait for the results.
20:09When I tell them that we may be a victim of a patient
20:12because there are no natural cells,
20:14there are no natural cells,
20:15but we don't have to do the results.
20:17It doesn't matter if someone wants to get sick,
20:24or if someone wants to get sick,
20:26or if someone wants to get sick,
20:29because there are many diseases
20:30and there are many diseases
20:33and there are many diseases
20:34that can be used by the treatment
20:36and treatment.
20:39Dr. Mohamed, I am today
20:41as a person,
20:42I have done the research that we talked about
20:44and it came out to me
20:46that there is an improvement of the treatment
20:48and I ask you for the first time
20:51Dr. Mohamed,
20:52how am I going to be a patient?
20:54Okay,
20:57normally when I come back to this kind of
20:59and I sit with the patient
21:00I take it with the patient
21:01who does different Crimin although,
21:05my hip hop said
21:07that there are still other system
21:08that it is a problem
21:09in its fatigue.
21:10Therefore, I need to do
21:12exerciseheus-led-led-led-led-led-led-led-led-led-led-led-led-led-led-led-led-led-led-led
21:18-led,匙
21:18folder-led-led-led-led-led-led-led-led. That's
21:20how we measure abaill had some confirms
21:20we also need toAbout one of
21:22the risks of the
21:23breast so we
21:25can see thesst
21:27biliator of the
21:27cl común which allows
21:28the airflow
21:29And through this discussion, I told her that this is one of the ones that we are looking for, but
21:38we are not able to do it.
21:40And this is a kind of a technical tool, which can take time.
21:48And this is why I am going to do these procedures.
21:52And I will see them again after these procedures.
21:55And through this period of time, we can do these procedures because of the disease.
22:02So the treatment will be a challenge for these procedures.
22:06So if there is a disease in the disease, or a disease in the disease, or a disease in the
22:13disease, there are some diseases that can help them.
22:17If there is such a disease in the disease, or something like that, we can help them to help them.
22:21And of course, if you need to do something or something in this period, it depends on the patient's condition.
22:28Now, when the patient comes to the patient, it is important that we have to make sure that we were
22:33in the chronic CML.
22:36So, I usually sit with the patient and say that this is the patient's condition and that the treatment is
22:44related to the treatment, which is very important.
22:49It's important that he understands that this treatment is important and it is important to take it.
22:54It is important to take it in the right way and it is healthy.
23:01And usually, I see the patient after a few weeks or two weeks, as I see how the treatment is
23:07from the patient's condition, which is the patient's condition, which I will tell you before it is due to the
23:14patient's condition.
23:16We can see the treatment in a very simple way through the days.
23:24It's important to follow the patient, but there are certain conditions, according to the guidelines,
23:36which we need to follow the patient.
23:39But it's important to know that he needs to be used in the treatment.
23:44When the patient comes back to the patient,
23:48there is a test from the patient.
23:54We know that there is a number of patients in the patient.
23:58And according to the patient, there is a number of patients in the patient.
24:05If the patient is not the same as the patient or the patient,
24:10we have to go back to the patient.
24:11There is also a treatment for the patient.
24:14And we can change the patient to the patient.
24:17So we can bring the patient to the patient,
24:20and the patient's treatment,
24:21and the patient's treatment can be the result of the treatment.
24:26We can bring the patient on the patient.
24:28It's a test from the patient.
24:33We have to go back to the patient.
24:42And we can bring the patient to the patient.
24:49We can bring the patient to the patient.
24:54We can bring the patient.
24:56Dr. Mohamad, that the patient must be able to keep the doctor, and it is important that he takes the
25:02doctor every day.
25:04At the same time he takes it, if he takes a little while, it's not a problem.
25:10But he must be able to take the doctor.
25:15And as we said before, that the patient will become a patient.
25:20And with the treatment, the patient will have a healthy life.
25:24And it will not affect the patient's life.
25:30And he will return to the doctor and he will be able to keep his life.
25:35Dr. Mohamad, you remember that the treatment of the first time, is there a couple of times?
25:44Dr. Mohamad, that's the first time.
25:46Dr. Mohamad, that is the first time to do the treatment of the patient, the patient will be able to
25:57get every week or two.
26:04Dr. Mohamad, that means that the
26:30It's very important that the doctor is very good.
26:33And as I said, it's almost 3 weeks after that.
26:37Because of the information, or the information that can affect their disease?
26:43Is it possible that this disease can affect their disease?
26:46It's definitely possible.
26:48The information that the disease is definitely affected by the patient's body.
26:54So it's very important that the patient can see the doctor and take the information from the doctor and the
27:06doctor can also say that any site can go to the internet or where are the information that you can
27:17share about the disease and the most important thing.
27:20What do you think about the doctor?
27:25This is really important.
27:27I would like to say to the viewers, as you mentioned, that there are people who want to know about
27:34the diseases and diseases before reaching the doctor to the doctor.
27:39They are always confident that they will take the information from the doctor.
27:43Thank you very much.
27:45Thank you very much.
27:47Thank you very much.
27:48Thank you very much.
27:53Thank you very much.
27:53I am very happy to be with you.
27:54I hope that the viewers are either going to be a disease or someone who is sick or someone who
28:02is sick or someone who is sick.
28:04Thank you very much.
28:14Thank you very much.
28:19I hope you've enjoyed the video.
28:21Thank you very much.
28:22I hope you will see your video on the next video.
28:24We'll see you next time.
Comments